UBS Sets Price Target for Comerica (NYSE:CMA) Amid Strong Financial Performance

Jul 21, 2025 4:10 PM - Stuart Mooney

Image credit: Google Images

On July 21, 2025, Nicholas Holowko from UBS set a price target of $64 for Comerica (NYSE:CMA). At that time, the stock was trading at $64.57, slightly above the target by about 0.88%. UBS maintained a neutral rating on Comerica, as highlighted by StreetInsider. This neutral stance comes despite Comerica's strong financial performance in the second quarter.

Comerica reported impressive earnings for the second quarter, surpassing analyst expectations. The company achieved earnings of $1.42 per share, exceeding the consensus estimate of $1.26 per share. Additionally, Comerica's quarterly sales reached $849 million, beating the expected $842.389 million. Following this positive earnings announcement, Comerica's shares rose by 4.7%, closing at $65.32 on Friday.

In response to the strong performance, several analysts adjusted their forecasts for Comerica. Keefe, Bruyette & Woods analyst Christopher Mcgratty maintained an Outperform rating for the company and increased the price target from $69 to $73. Similarly, Stephens & Co. analyst Terry McEvoy maintained an Equal-Weight rating and raised the price target from $61 to $68. These adjustments reflect a positive outlook on Comerica's future performance.

The current stock price of CMA is $64.70, reflecting a decrease of approximately 0.96% or $0.63. Today, the stock has traded between a low of $64.39 and a high of $65.49. Over the past year, CMA has reached a high of $73.45 and a low of $48.12. The company's market capitalization stands at approximately $8.5 billion. Today's trading volume for CMA is 1,302,402 shares on the NYSE.

Other Blogs

Nov 22, 2024 5:08 AM - Parth Sanghvi

Fundamental Analysis: Principles, Types, and How to Use It

Fundamental analysis is one of the most essential tools for investors and analysts alike, helping them assess the intrinsic value of a stock, company, or even an entire market. It focuses on the financial health and economic position of a company, often using key data such as earnings, expenses, ass...

Dec 17, 2024 8:58 AM - Sanzhi Kobzhan

Examining Tesla’s Financial Health Using FinancialModelingPrep’s Ratios API

Tesla, one of the world’s most talked-about electric vehicle manufacturers, attracts a lot of attention from investors and market watchers. By examining a snapshot of Tesla’s financial ratios—such as those provided by FinancialModelingPrep’s Ratios API—we can get a clearer picture of the company’s f...

Dec 22, 2024 7:59 AM - Sanzhi Kobzhan

Two great Software Platform Stocks Similar to Palantir (PLTR)

When it comes to cutting-edge software and data analytics, Palantir Technologies (NYSE: PLTR) is often front and center. But for many investors, it’s important to consider alternative or complementary stocks in the same sector that may offer robust growth potential. As PLTR looks expensive (overvalu...